Decoding the historical tale: COVID-19 impact on haematological malignancy patients: EPICOVIDEHA insights from 2020 to 2022
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F24%3A00013648" target="_blank" >RIV/00023736:_____/24:00013648 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/24:00137430 RIV/65269705:_____/24:00080457 RIV/00179906:_____/24:10484297 RIV/00064173:_____/24:43927649 and 2 more
Result on the web
<a href="https://doi.org/10.1016/j.eclinm.2024.102553" target="_blank" >https://doi.org/10.1016/j.eclinm.2024.102553</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.eclinm.2024.102553" target="_blank" >10.1016/j.eclinm.2024.102553</a>
Alternative languages
Result language
angličtina
Original language name
Decoding the historical tale: COVID-19 impact on haematological malignancy patients: EPICOVIDEHA insights from 2020 to 2022
Original language description
The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals, and monoclonal antibodies have been effective for the general population, their benefits for these patients may not be as pronounced. The EPICOVIDEHA registry (National Clinical Trials Identifier, NCT04733729) gathers COVID-19 data from hematological malignancy patients since the pandemic's start worldwide. It spans various global locations, allowing comprehensive analysis over the first three years (2020–2022). Patients with hematological malignancies still face elevated risks, despite reductions in critical infections and overall mortality rates over time. Hospitalization, especially in ICUs, remains a significant concern. The study underscores the importance of vaccination and the timing of COVID-19 exposure in 2022 for enhanced survival in this patient group. Ongoing monitoring and targeted interventions are essential to support this vulnerable population, emphasizing the critical role of timely diagnosis and prompt treatment in preventing severe COVID-19 cases.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
EClinical medicine
ISSN
2589-5370
e-ISSN
—
Volume of the periodical
71
Issue of the periodical within the volume
May
Country of publishing house
GB - UNITED KINGDOM
Number of pages
20
Pages from-to
"art. no. 102553"
UT code for WoS article
001311054400001
EID of the result in the Scopus database
2-s2.0-85188194524